newsfilter
← Latest News
Business Wire·

Pear Therapeutics and SelectHealth Announce Coverage to Provide Access to FDA-Authorized Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder

SelectHealth teams with Pear to provide its members with covered access to Pear's innovative prescription digital therapeutic (PDT), reSET-O®, for the treatment of opioid use disorder (OUD) as adjunct to outpatient treatment that includes transmucosa